May 22, 2017 / 6:10 AM / 2 months ago

BRIEF-Midatech Pharma proceeds with testing for glioblastoma brain cancer

1 Min Read

May 22 (Reuters) - Midatech Pharma Plc:

* Has selected its preferred candidate for testing in glioblastoma (gbm) brain cancer

* Compound is under final evaluation with some key pre-clinical studies to confirm efficacy before being progressed into IND enabling trials

* Additional candidates are also being evaluated in parallel Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below